ロード中...
Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab
We report the experience of reversing dabigatran prior to administering systemic thrombolysis for acute ischaemic cerebellar stroke, which was well tolerated with no haemorrhagic complications after thrombolysis. Given the increasingly common use of dabigatran for atrial fibrillation, the use of ida...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6506077/ https://ncbi.nlm.nih.gov/pubmed/31061182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-229128 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|